Patterns of age disparities in colon and lung cancer survival: a systematic narrative literature review.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 03 2021
Historique:
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 20 5 2021
Statut: epublish

Résumé

To identify patterns of age disparities in cancer survival, using colon and lung cancer as exemplars. Systematic review of the literature. We searched Embase, MEDLINE, Scopus and Web of Science through 18 December 2020. We retained all original articles published in English including patients with colon or lung cancer. Eligible studies were required to be population-based, report survival across several age groups (of which at least one was over the age of 65) and at least one other characteristic (eg, sex, treatment). Two independent reviewers extracted data and assessed the quality of included studies against selected evaluation domains from the QUIPS tool, and items concerning statistical reporting. We evaluated age disparities using the absolute difference in survival or mortality rates between the middle-aged group and the oldest age group, or by describing survival curves. Out of 3047 references, we retained 59 studies (20 for colon, 34 for lung and 5 for both sites). Regardless of the cancer site, the included studies were highly heterogeneous and often of poor quality. The magnitude of age disparities in survival varied greatly by sex, ethnicity, socioeconomic status, stage at diagnosis, cancer site, and morphology, the number of nodes examined and treatment strategy. Although results were inconsistent for most characteristics, we consistently observed greater age disparities for women with lung cancer compared with men. Also, age disparities increased with more advanced stages for colon cancer and decreased with more advanced stages for lung cancer. Although age is one of the most important prognostic factors in cancer survival, age disparities in colon and lung cancer survival have so far been understudied in population-based research. Further studies are needed to better understand age disparities in colon and lung cancer survival. CRD42020151402.

Identifiants

pubmed: 33692182
pii: bmjopen-2020-044239
doi: 10.1136/bmjopen-2020-044239
pmc: PMC7949400
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e044239

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

CA Cancer J Clin. 2016 Jul;66(4):337-50
pubmed: 26891458
Thorax. 2011 Apr;66(4):301-7
pubmed: 21199818
Lancet Oncol. 2014 Jan;15(1):23-34
pubmed: 24314615
Cancer. 2017 Aug 1;123(15):2840-2849
pubmed: 28346663
J Clin Oncol. 2010 May 20;28(15):2520-8
pubmed: 20406936
Ann Coloproctol. 2018 Aug;34(4):212-221
pubmed: 30208684
J Epidemiol. 2019 Mar 5;29(3):110-115
pubmed: 30012908
J Thorac Dis. 2020 Sep;12(9):4670-4679
pubmed: 33145040
PLoS One. 2019 Jun 27;14(6):e0219206
pubmed: 31247015
Cancer Epidemiol. 2016 Oct;44:77-83
pubmed: 27513721
N Engl J Med. 1999 Dec 30;341(27):2061-7
pubmed: 10615079
Br J Cancer. 2019 May;120(11):1052-1058
pubmed: 31040385
BMC Cancer. 2020 Jan 6;20(1):19
pubmed: 31906959
Lung Cancer. 2015 Dec;90(3):528-33
pubmed: 26480866
Clin Colorectal Cancer. 2018 Sep;17(3):e549-e555
pubmed: 29861156
Oncotarget. 2017 May 23;8(21):34923-34934
pubmed: 28432275
Eur J Cancer. 2012 Jan;48(2):270-8
pubmed: 22093945
Eur J Cancer. 2013 Feb;49(3):585-92
pubmed: 22967727
PLoS One. 2016 May 19;11(5):e0155608
pubmed: 27196666
Oncologist. 2012;17(10):1294-302
pubmed: 22826374
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Eur J Surg Oncol. 2014 Nov;40(11):1474-80
pubmed: 25027280
Endocr Rev. 2012 Feb;33(1):1-47
pubmed: 22240244
Ann Oncol. 2012 Oct;23(10):2479-2516
pubmed: 23012255
Cancer Epidemiol. 2010 Dec;34(6):667-81
pubmed: 20466612
Lung Cancer. 2020 Jun;144:64-70
pubmed: 32371262
Int J Cancer. 2010 Aug 15;127(4):924-31
pubmed: 19998335
Int J Cancer. 2019 Jan 1;144(1):49-58
pubmed: 29978474
Eur J Cancer. 2009 Apr;45(6):1006-16
pubmed: 19121578
J Geriatr Oncol. 2019 Jul;10(4):547-554
pubmed: 30876833
J Clin Oncol. 2014 Aug 20;32(24):2595-603
pubmed: 25071125
Arch Intern Med. 2003 Oct 13;163(18):2135-44
pubmed: 14557210
PLoS One. 2013 Jul 05;8(7):e68077
pubmed: 23861851
Jpn J Clin Oncol. 2017 Sep 1;47(9):863-869
pubmed: 28903532
Eur J Cancer. 2015 Oct;51(15):2242-2253
pubmed: 26421826
J Natl Compr Canc Netw. 2020 Sep;18(9):1230-1237
pubmed: 32886900
Oncol Lett. 2020 Aug;20(2):1607-1618
pubmed: 32724402
Semin Surg Oncol. 1994 Jan-Feb;10(1):21-30
pubmed: 8115783
Thorax. 2019 Jan;74(1):51-59
pubmed: 30100577
JAMA Oncol. 2015 Apr;1(1):88-96
pubmed: 26182310
Ann Oncol. 2010 Nov;21(11):2206-2212
pubmed: 20439339
J Clin Oncol. 2003 Apr 1;21(7):1383-9
pubmed: 12663731
J Thorac Oncol. 2014 Mar;9(3):355-61
pubmed: 24496005
Br J Cancer. 1995 Aug;72(2):511-8
pubmed: 7640241
Chest. 2020 Nov 17;:
pubmed: 33217414
N Z Med J. 2010 Mar 05;123(1310):50-61
pubmed: 20360779
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):145-86
pubmed: 25417231
Cancer Invest. 2019;37(8):355-366
pubmed: 31437020
Diagn Progn Res. 2018 Jan 10;2:1
pubmed: 31093551
Lung. 2017 Oct;195(5):627-634
pubmed: 28631153
Lancet Oncol. 2019 Nov;20(11):1493-1505
pubmed: 31521509
Lung Cancer. 2017 Jun;108:198-204
pubmed: 28625635
Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):271-82
pubmed: 9568781
J Thorac Oncol. 2012 Feb;7(2):291-8
pubmed: 22157366
Cancer Control. 2014 Jul;21(3):215-20
pubmed: 24955705
Eur J Cancer. 2007 Oct;43(15):2194-202
pubmed: 17884463
Acta Oncol. 1999;38 Suppl 12:1-103
pubmed: 10225326
Clin Epidemiol. 2013 Nov 01;5(Suppl 1):31-8
pubmed: 24227921
J Thorac Oncol. 2012 Jan;7(1):227-32
pubmed: 22071783
Dig Surg. 2012;29(5):412-9
pubmed: 23235489
Br J Surg. 2011 May;98(5):716-23
pubmed: 21341253
Med Care. 2019 Apr;57(4):286-294
pubmed: 30789540
Eur J Surg Oncol. 2011 Oct;37(10):904-12
pubmed: 21784608
Cancer Sci. 2020 Aug;111(8):2965-2973
pubmed: 32441434
Front Oncol. 2019 Jul 03;9:593
pubmed: 31334118
J Geriatr Oncol. 2019 Jan;10(1):138-142
pubmed: 29960748
Acta Oncol. 2019 Nov;58(11):1549-1556
pubmed: 31286812
J Clin Oncol. 2018 Aug 1;36(22):2326-2347
pubmed: 29782209
Eur J Cancer Care (Engl). 2015 Mar;24(2):163-78
pubmed: 25657076
Ann Coloproctol. 2013 Aug;29(4):144-9
pubmed: 24032114
Lung Cancer. 2014 Dec;86(3):350-7
pubmed: 25439437
Int J Epidemiol. 2010 Apr;39(2):598-610
pubmed: 20142331
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
J Geriatr Oncol. 2020 Mar;11(2):274-279
pubmed: 31501014
PLoS One. 2012;7(8):e44325
pubmed: 22957007
Cancer Epidemiol. 2013 Jun;37(3):226-32
pubmed: 23510644
J Epidemiol Community Health. 2010 Feb;64(2):117-23
pubmed: 20056966
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
Ann Intern Med. 2013 Feb 19;158(4):280-6
pubmed: 23420236
J Geriatr Oncol. 2018 Jan;9(1):6-14
pubmed: 29030150
BMC Cancer. 2015 Feb 19;15:72
pubmed: 25886269
Thorax. 2004 Jul;59(7):602-7
pubmed: 15223870
Cancer Epidemiol. 2015 Aug;39(4):641-9
pubmed: 26143284
Lung Cancer. 2018 Feb;116:55-61
pubmed: 29413051
Cancer. 1998 Jun 1;82(11):2123-34
pubmed: 9610691
Eur J Cancer. 2009 Apr;45(6):931-91
pubmed: 19171476
Cancer Causes Control. 2004 Nov;15(9):903-10
pubmed: 15577292
Cancer. 2019 Feb 1;125(3):473-481
pubmed: 30508291
Br J Cancer. 2015 Jun 30;113(1):173-81
pubmed: 26079299
BMC Cancer. 2019 Jul 25;19(1):735
pubmed: 31345187
Med Care. 2014 Jul;52(7):586-93
pubmed: 24926705
Br J Cancer. 2017 Jan;116(3):389-397
pubmed: 28056465
Clin Epidemiol. 2019 Jan 03;11:53-65
pubmed: 30655705
Cancer Res Treat. 2013 Sep;45(3):162-71
pubmed: 24155674
Lancet. 2018 May 5;391(10132):1775-1782
pubmed: 29706364
Ann Oncol. 1998 May;9(5):543-7
pubmed: 9653496
Ann Surg Oncol. 2009 Jul;16(7):1912-7
pubmed: 19408051
Int J Cancer. 2021 Apr 1;148(7):1575-1585
pubmed: 33006395

Auteurs

Sophie Pilleron (S)

Department of Public Health, School of Medicine, University of Otago, Wellington, New Zealand sophie.pilleron@gmail.com.

Helen Gower (H)

Department of Surgery and Anaesthesia, Surgical Cancer Research Group, University of Otago, Wellington, New Zealand.

Maryska Janssen-Heijnen (M)

Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands.
Department of Epidemiology, Maastricht University Medical Centre+, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands.

Virginia Claire Signal (VC)

Department of Public Health, School of Medicine, University of Otago, Wellington, New Zealand.

Jason K Gurney (JK)

Department of Public Health, School of Medicine, University of Otago, Wellington, New Zealand.

Eva Ja Morris (EJ)

Nuffield Department of Population Health, University of Oxford, Big Data Institute, Oxford, UK.

Ruth Cunningham (R)

Department of Public Health, School of Medicine, University of Otago, Wellington, New Zealand.

Diana Sarfati (D)

New Zealand Cancer Control Agency, Wellington, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH